1. Home
  2. CVEO vs OBIO Comparison

CVEO vs OBIO Comparison

Compare CVEO & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Civeo Corporation (Canada)

CVEO

Civeo Corporation (Canada)

HOLD

Current Price

$31.24

Market Cap

297.0M

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$4.17

Market Cap

246.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVEO
OBIO
Founded
1977
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.0M
246.2M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
CVEO
OBIO
Price
$31.24
$4.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$37.00
$14.25
AVG Volume (30 Days)
61.9K
115.2K
Earning Date
05-01-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.13
EPS
N/A
N/A
Revenue
N/A
$33,482,000.00
Revenue This Year
$7.72
N/A
Revenue Next Year
$5.61
$12.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1169.22
52 Week Low
$18.01
$2.20
52 Week High
$31.26
$5.42

Technical Indicators

Market Signals
Indicator
CVEO
OBIO
Relative Strength Index (RSI) 72.44 42.90
Support Level $22.20 $4.02
Resistance Level N/A $4.17
Average True Range (ATR) 0.88 0.24
MACD 0.30 -0.03
Stochastic Oscillator 96.72 18.88

Price Performance

Historical Comparison
CVEO
OBIO

About CVEO Civeo Corporation (Canada)

Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, and Australia. It derives maximum revenue from Australia.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Share on Social Networks: